CA9 and breast carcinoma: The lung cancer epidermal growth factor receptor (EGFR; PDBID: 5HG8) and breast cancer carbonic anhydrase IX (CAIX; PDBID: 6NLV) proteins were selected as receptors with the title compound as a ligand.